Le Lézard
Classified in: Science and technology
Subjects: LEG, POL, AVO

AMTP Welcomes CHIPS Act Funding; Says More Needs to Be Done


The following statement from Brewer Science Executive Vice President and AMTP Executive Director Dan Brewer in response to the final adoption of CHIPS Act funding signed earlier today by President Biden to help boost the U.S.-based semiconductor supply chain.

ROLLA, Mo, Aug. 9, 2022 /PRNewswire/ -- "AMTP welcomes bipartisan adoption of CHIPS Act funding and its related provisions to secure and bolster domestic semiconductor production here in the United States. It is important to note, however, that more needs to be done to ensure our economic and national security, which is increasingly dependent upon such essential microelectronic components.

"In addition to spurring the domestic manufacture of these critical components, we believe Congress must also find additional ways to recognize and support the materials and supply chains necessary for any such expanded manufacturing capacity.

"Congress and the Biden Administration also need to re-examine the pending expiration of federal tax provisions designed to support science and technology research and development. At a time when our microelectronic supply chains and essential components are at risk, it would be an overall step backward to allow such incentives to lapse."

americanmaterialstechpartnership.org

SOURCE Brewer Science


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: